|Bid||168.32 x 900|
|Ask||291.60 x 1300|
|Day's Range||210.73 - 217.62|
|52 Week Range||194.67 - 285.61|
|Beta (5Y Monthly)||1.46|
|PE Ratio (TTM)||54.01|
|Earnings Date||Apr 20, 2022 - Apr 25, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||263.13|
IQV vs. APP: Which Stock Is the Better Value Option?
IQVIA's (IQV) enormous treasure trove of information is a distinguishing asset.
RESEARCH TRIANGLE PARK, N.C., June 07, 2022--IQVIA (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and contract services to the life sciences industry, today announced the appointment of Dr. Christina Mack to serve as chief scientific officer for the company’s Real World Solutions (RWS) business, effective July 7, 2022. Christina is succeeding Dr. Nancy Dreyer, who is retiring after nearly two decades with IQVIA.